Sponsor or institution
Clinical trials and research at OPKO Health, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by OPKO Health, Inc. that are recruiting, in United States. By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
OPK-88006 in Healthy Adults and People with Presumed MASH
This study tests OPK-88006 to see if it is safe and how it behaves in the body, first in healthy adults and then in people with presumed MASH.
-
CTAP101 extended-release capsules in kids with CKD and vitamin D insufficiency
A daily bedtime dose of CTAP101 is being tested in children with CKD stages 3–4 and secondary hyperparathyroidism to see how the drug moves in the body, how it affects the body, and whether it is safe and tolerable.
Quick answers
How many clinical trials run by OPKO Health, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.